Intra-operative Hyperspectral Imaging in Neurosurgery

Launched by KING'S COLLEGE LONDON · Mar 15, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new imaging technology called hyperspectral imaging (HSI) to improve brain surgery, specifically for patients with brain tumors or blood vessel issues in the brain. The goal is to help surgeons see and identify tumors and important brain structures more clearly during surgery, which could lead to better outcomes for patients. Currently, about 30% of patients who have brain tumor surgery may need additional operations because some tumor remains after the first surgery. By using HSI, the hope is to reduce this number, making surgeries safer and more effective.

To participate in the trial, you need to be an adult (18 years or older) scheduled for elective brain surgery, either for a tumor or for conditions like arteriovenous malformations (AVM) or aneurysms. If you qualify and decide to join, you will have your surgery as planned, and the HSI system will be used to gather detailed images during the procedure. This information will help researchers develop better ways to interpret the images in real-time, ultimately aiming to improve surgical outcomes for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients aged 18 years and over
• • Patients with a diagnosis of a brain tumour (any type), AVM or aneurysm who are scheduled for elective surgery
• • Patients able to provide written informed consent
• Exclusion Criteria:
• • Patients under 18 years of age
• • Patients who have previously had brain surgery